deltatrials
Terminated OBSERVATIONAL NCT02016677

An Observational Study Exploring the Esthetic Outcomes of Breast Reduction Surgery and /or Mastopexy

Sponsor: Orbix Medical Ltd.

Conditions Macromastia
Updated 6 times since 2017 Last updated: Dec 22, 2015 Started: Dec 31, 2013 Primary completion: Nov 30, 2015 Completion: Nov 30, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Slow enrollment rate. Low scientific value

Listed as NCT02016677, this observational or N/A phase trial focuses on Macromastia and remains terminated or withdrawn. Sponsored by Orbix Medical Ltd., it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshotTerminated~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated

  5. Apr 2018 — Jun 2018 [monthly]

    Terminated

    Phase: NANone

Show 1 earlier version
  1. Jan 2017 — Apr 2018 [monthly]

    Terminated NA

    First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Orbix Medical Ltd.
Data source: Orbix Medical Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations